Dr Mark Prentice, Consultant Clinical Oncologist

Dr Mark Prentice

Consultant Clinical Oncologist

Book online
|

Dr Mark Prentice MBChB BSC(Hons) AKC MRCP FRCR

Consultant Clinical Oncologist

MBChB BSC(Hons) AKC MRCP FRCR

Dr Mark Prentice

Consultant Clinical Oncologist MBChB BSC(Hons) AKC MRCP FRCR

Book online
|
MBChB BSC(Hons) AKC MRCP FRCR
HCA-Healthcare-UK

Areas of expertise

  • Bladder cancer
  • Prostate cancer
  • Renal cancer
  • Uro-oncology - prostate
  • Rradio-ligand therapy
HCA-Healthcare-UK

Address

About Dr Mark Prentice

GMC number: 6160554

Year qualified: 2007

Place of primary qualification: Leicester Warwick Medical School

Dr Mark Prentice is a distinguished consultant specialising in uro-oncology, focusing on prostate, bladder, and renal cancers. Dr Prentice is highly regarded for his expertise in novel radiotherapy techniques, radio-ligand therapy, and the hormonal manipulation of prostate cancer.

In addition to his clinical practice, Dr Prentice is deeply committed to the management of older people with cancer, ensuring they receive tailored and compassionate care. He is the principal investigator for multiple clinical trials, contributing significantly to advancements in cancer treatment. His work has also led to the development of international guidelines on prostate cancer management, reflecting his dedication to improving patient outcomes globally.

Dr Prentice's roles extend beyond patient care; he is actively involved in research and education, mentoring the next generation of medical professionals. His interests in innovative treatment methods and comprehensive cancer care make him a leading figure in the field of uro-oncology.

Areas of expertise

  • Bladder cancer
  • Hormonal manipulation of prostate cancer
  • Management of older people with cancer
  • Prostate cancer
  • Renal cancer
  • Rradio-ligand therapy
  • Uro-oncology - prostate

Professional memberships

General Medical Council